澳大利亚新南威尔士大学的一位教授最近在抗衰老药物研究方面取得突破性进展,人类想要长生不老的愿望或许终有一天会成为现实。这位教授发现,人体内有一种抗衰老酶能够防止衰老性疾病,同时延长寿命。这位教授发现,他研究中使用的117种药物均通过相同的原理作用于这种酶。这一发现说明,研究人员可以通过深入研究研发出一种可以治疗某种重大疾病、同时防止其他多种疾病的药物,从而达到延缓衰老的目的。目前,一系列病理试验均显乐观,这种药物有望在2018年以前面世。
Man's search for immortality is another step closer to reality with a major breakthrough in creating a drug capable of fighting the aging process -- a drug that could be available before 2018 -- after pioneering work led by an Australian researcher with the University of New South Wales (UNSW).
The study led by Professor David Sinclair, from UNSW Medicine, has revealed that a single anti-aging enzyme in the body has the potential to prevent age-related diseases and extend lifespans.
The paper released this month, shows all of the 117 drugs tested work on the single enzyme through a common mechanism.
These consequences are far-ranging and suggest that an entirely new class of anti-aging drugs are now viable.
Drugs that could ultimately prevent the great diseases of our lifetime -- from cancer, Parkinson's Disease, Alzheimer's disease and even the burden of modern lifestyles -- type 2 diabetes.
【澳科学家研制抗衰老药有突破 长生不老或不再是神话】相关文章:
★ 男性避孕药出来了
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15